Novo Nordisk Threatens Lawsuit Over Cheap Hims Copy of Wegovy Pill
Novo Nordisk is planning legal and regulatory action against telehealth provider Hims & Hers after they announced it would sell a lower cost weight-loss pill.
ROC CEO B. Scott Swann joins us live from the NYSE to discuss the company's IPO and how VisionAI is transforming facial recognition for defense and security.
Matternet founder and CEO Andreas Raptopoulos on the state of drone delivery in the U.S. and what it will take to make aerial delivery a mainstream reality.